Publication date: Sep 08, 2025
Serine protease inhibitors (SERPINs) are involved in various physiological processes and diseases, such as inflammation, cancer metastasis, and neurodegeneration. Their role in viral infections is poorly understood, as their expression patterns during infection and the range of proteases they target have yet to be fully characterized. Here, we show widespread expression of human SERPINs in response to respiratory virus infections, both in bronchioalveolar lavages from COVID-19 patients and in polarized human airway epithelial cultures. Using in silico docking of 10 SERPINs to 48 host proteases, we confirm known targets and predict new interactions. Protease activity assays validated selected interactions, confirming the newly predicted host targets for PAI-1 (SERPINE1) and PAI-2 (SERPINB2). PAI-1 inhibits cathepsin L, essential for SARS-CoV-2 maturation, and suppresses multi-cycle replication of both ancestral SARS-CoV-2 WA-1 and its variant Omicron BA. 1. In addition, we identify PAI-2 as an antiviral SERPIN that reduces infectivity of human adenovirus 5 by directly inhibiting the adenoviral protease. Our study leverages in silico docking using full-length 3D protein structures to uncover new SERPIN targets, offering a range of candidate targets for therapeutic interventions.
| Concepts | Keywords |
|---|---|
| Adenovirus | Adenovirus Protease |
| Covid | Cathepsin |
| Host | Plasminogen Activator Inhibitor 1 |
| Neurodegeneration | Plasminogen Activator Inhibitor 2 |
| Viral | TMPRSS |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | inflammation |
| disease | MESH | cancer |
| disease | MESH | metastasis |
| disease | IDO | role |
| disease | MESH | viral infections |
| disease | MESH | infection |
| disease | MESH | COVID-19 |
| disease | IDO | host |
| disease | IDO | replication |
| disease | IDO | infectivity |
| disease | IDO | protein |